Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Canada; Division of Neurology, University of Toronto, Toronto, Canada; Krembil Brain Institute, University Health Network, Toronto, Canada; Center for Advancing Neurotechnological Innovation to Application, Toronto, Canada.
Center for Neuromodulation, Department of Neurosurgery, Kurashiki Heisei Hospital, Kurashiki, Japan.
Neurobiol Dis. 2024 Sep;199:106589. doi: 10.1016/j.nbd.2024.106589. Epub 2024 Jul 3.
Despite the large body of work on local field potentials (LFPs), a measure of oscillatory activity in patients with Parkinson's disease (PD), the longitudinal evolution of LFPs is less explored.
To determine LFP fluctuations collected in clinical settings in patients with PD and STN deep brain stimulation (DBS).
Twenty-two STN-DBS patients (age: 67.6 ± 8.3 years; 9 females; disease duration: 10.3 ± 4.5 years) completed bilateral LFP recordings over three visits in the OFF-stimulation setting. Peak and band power measures were calculated from each recording.
After bilateral LFP recordings, at least one peak was detected in 18 (81.8%), 20 (90.9%), and 22 (100%) patients at visit 1, 2, and 3, respectively. No significant differences were seen in primary peak amplitude (F = 2.91, p = 0.060) over time. Amplitude of the second largest peak (F = 5.49, p = 0.006) and low-beta (F = 6.89, p = 0.002), high-beta (F = 13.23, p < 0.001), and gamma (F = 12.71, p < 0.001) band power demonstrated a significant effect of time. Post hoc comparisons determined low-beta power (Visit 1-Visit 2: t = 3.59, p = 0.002; Visit 1-Visit 3: t = 2.61, p = 0.031), high-beta (Visit 1-Visit 2: t = 4.64, p < 0.001; Visit 1-Visit 3: t = 4.23, p < 0.001) and gamma band power (Visit 1-Visit 2: t = 4.65, p < 0.001; Visit 1-Visit 3: t = 4.00, p < 0.001) were significantly increased from visit 1 recordings to both follow-up visits.
Our results provide substantial evidence that LFP can reliably be detected across multiple real-world clinical visits in patients with STN-DBS for PD. Moreover, it provides insights on the evolution of these LFPs.
尽管已有大量关于局部场电位(LFPs)的研究,即帕金森病(PD)患者的振荡活动的测量,但 LFPs 的纵向演变研究较少。
确定在 PD 患者和 STN 深部脑刺激(DBS)的临床环境中收集的 LFP 波动。
22 名接受 STN-DBS 治疗的 PD 患者(年龄:67.6±8.3 岁;9 名女性;疾病持续时间:10.3±4.5 年)在 OFF-刺激设置下完成了三次双侧 LFP 记录。从每个记录中计算峰和频带功率测量值。
在双侧 LFP 记录后,分别在第 1、2 和 3 次就诊时,18 名(81.8%)、20 名(90.9%)和 22 名(100%)患者检测到至少一个峰值。在时间上,主要峰值幅度没有显著差异(F=2.91,p=0.060)。第二大峰值(F=5.49,p=0.006)、低β(F=6.89,p=0.002)、高β(F=13.23,p<0.001)和γ(F=12.71,p<0.001)频带功率的幅度显示出时间的显著影响。事后比较确定低β功率(第 1 次就诊-第 2 次就诊:t=3.59,p=0.002;第 1 次就诊-第 3 次就诊:t=2.61,p=0.031)、高β(第 1 次就诊-第 2 次就诊:t=4.64,p<0.001;第 1 次就诊-第 3 次就诊:t=4.23,p<0.001)和γ频带功率(第 1 次就诊-第 2 次就诊:t=4.65,p<0.001;第 1 次就诊-第 3 次就诊:t=4.00,p<0.001)均显著增加从第 1 次就诊记录到两次随访就诊。
我们的研究结果提供了充分的证据表明,在接受 STN-DBS 治疗的 PD 患者的多个真实世界临床就诊中,LFP 可以可靠地检测到。此外,它还提供了有关这些 LFPs 演变的见解。